Bicara Therapeutics Mean Deviation
| BCAX Stock | | | 22.65 -0.19 -0.83% |
The mean deviation of the equity instrument is the first measure of the distances between each value of security historical prices and the mean. It gives us an idea of how spread out from the center the distribution of returns. Below is Bicara Therapeutics's current Mean Deviation with peer comparisons and related risk metrics.
Current Mean Deviation Value
Bicara Therapeutics registers a Mean Deviation of 2.49, reflecting moderate price variability. This places Bicara Therapeutics within the typical volatility range for Biotechnology.
Mean Deviation | = | SUM(RET DEV)N |
| = | 2.49 | |
| SUM | = | Summation notation |
| RET DEV | = | Sum of return deviations of Bicara Therapeutics |
| N | = | Number of calculation points for selected time horizon |
Mean Deviation Peers Comparison
Bicara Therapeutics's Mean Deviation of 2.49 falls below the 3.1 peer average. Values range from 2.25 (Kura Oncology) to 3.79 (Prime Medicine Common), with tight clustering across the group. Bicara Therapeutics has exhibited less price dispersion than the peer average over the measured period.
Mean Deviation Relative To Other Indicators
The chart below plots Mean Deviation against Maximum Drawdown for Bicara Therapeutics and its peers. Each point represents one equity — position along the horizontal axis shows Mean Deviation while the vertical axis shows Maximum Drawdown. Equities that cluster in different quadrants carry distinct risk-return profiles. Use the dropdowns to swap in other indicators for either axis.
Bicara Therapeutics's Maximum Drawdown of
12.53 runs about
5.03 times its Mean Deviation of
2.49 . This indicates Maximum Drawdown substantially exceeds Mean Deviation for Bicara Therapeutics.
Methodology, Assumptions & Data Sources
Bicara Therapeutics has a current Mean Deviation reading of 2.49. The Mean Deviation for Bicara Therapeutics applies a standardized calculation to daily closing prices and, where applicable, volume data across the selected period. Data sources include daily closing prices from supported exchanges, with standard corporate action adjustments applied. Bicara Therapeutics operates in the health care sector, which may exhibit distinct volatility and momentum characteristics relative to the broader market. Results are based on historical returns and do not predict future performance. This indicator is provided for informational purposes.
Other Technical Indicators